Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Copper Catalyzed Borylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103030656B details a novel catalytic route for bortezomib, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN102659919A details a cost-effective bortezomib synthesis using (R)-tert-butylsulfinamide, offering high purity and scalable manufacturing for global supply chains.